Neuroprotection: A comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide

被引：96
作者：
Brenneman, Douglas E. [1 ]
机构：
[1] Johnson & Johnson Pharmaceut Res & Dev, Spring House, PA 19477 USA
来源：
PEPTIDES | 2007年 / 28卷 / 09期
关键词：
excitotoxicity; astrocytes; chemokines; MAPK; cAMP; calcium; growth factors; second messengers; secretion; receptors; gp120;
D O I：
10.1016/j.peptides.2007.04.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The neuroprotective properties of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) place these peptides in a special category of ligands that have implications for our understanding of pathological conditions as well as a potential basis for therapeutic intervention. It is remarkable that these peptides have a protective impact against such a wide variety of clinical relevant toxic substances. This protective diversity is consistent with the multiple pathways that are activated or inhibited by the action of these peptides. Although knowledge is emerging on the neuroprotective mechanisms of VIP and PACAP, it is already evident that these two peptides are not identical in their action and each peptide has multiple mechanisms that allow for neuroprotective diversity. The multiple intracellular signaling pathways and differing extracellular mediators of neuroprotection contribute to this diversity of action. in this review, examples of neuroprotective actions will be presented that serve to demonstrate the remarkable breadth of neuroprotective processes produced by VIP and PACAP. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：1720 / 1726
页数：7
相关论文
共 42 条
[1]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[2]   PACAP FUNCTIONS AS A NEUROTROPHIC FACTOR [J].
ARIMURA, A ;
SOMOGYVARIVIGH, A ;
WEILL, C ;
FIORE, RC ;
TATSUNO, I ;
BAY, V ;
BRENNEMAN, DE .
MODELS OF NEUROPEPTIDE ACTION, 1994, 739 :228-243
[3]   Microiontophoretically applied PACAP blocks excitatory effects of kainic acid in vivo [J].
Atlasz, Tamas ;
Koszegi, Zsombor ;
Babai, Norbert ;
Tamas, Andrea ;
Reglodi, Dora ;
Kovacs, Peter ;
Hernadi, Istvan ;
Gabriel, Robert .
VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY, 2006, 1070 :143-148
[4]   Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide [J].
Bassan, M ;
Zamostiano, R ;
Davidson, A ;
Pinhasov, A ;
Giladi, E ;
Perl, O ;
Bassan, H ;
Blat, C ;
Gibney, G ;
Glazner, G ;
Brenneman, DE ;
Gozes, I .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :1283-1293
[5]   Complex array of cytokines released by vasoactive intestinal peptide [J].
Brenneman, DE ;
Phillips, TM ;
Hauser, J ;
Hill, JM ;
Spong, CY ;
Gozes, I .
NEUROPEPTIDES, 2003, 37 (02) :111-119
[6]   NEURONAL CELL KILLING BY THE ENVELOPE PROTEIN OF HIV AND ITS PREVENTION BY VASOACTIVE INTESTINAL PEPTIDE [J].
BRENNEMAN, DE ;
WESTBROOK, GL ;
FITZGERALD, SP ;
ENNIST, DL ;
ELKINS, KL ;
RUFF, MR ;
PERT, CB .
NATURE, 1988, 335 (6191) :639-642
[7]   VASOACTIVE-INTESTINAL-PEPTIDE AND ELECTRICAL-ACTIVITY INFLUENCE NEURONAL SURVIVAL [J].
BRENNEMAN, DE ;
EIDEN, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (04) :1159-1162
[8]   Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity [J].
Brenneman, DE ;
Hauser, JM ;
Spong, CY ;
Phillips, TM .
NEUROPEPTIDES, 2002, 36 (04) :271-280
[9]   NONNEURONAL CELLS MEDIATE NEUROTROPHIC ACTION OF VASOACTIVE-INTESTINAL-PEPTIDE [J].
BRENNEMAN, DE ;
NEALE, EA ;
FOSTER, GA ;
DAUTREMONT, SW ;
WESTBROOK, GL .
JOURNAL OF CELL BIOLOGY, 1987, 104 (06) :1603-1610
[10]   A femtomolar-acting neuroprotective peptide [J].
Brenneman, DE ;
Gozes, I .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) :2299-2307
12345